SCHEMBL9760762

SCHEMBL9760762

COC(=O)C1=C(C)N(OC(=O)/C=C/C(=O)ON2C(C)=C(C(=O)OC)[C@H](c3cccc(Cl)c3Cl)C(C(=O)OCC(C)C)=C2COCCOCCN)C(COCCOCCN)=C(C(=O)OCC(C)C)[C@H]1c1cccc(Cl)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1C Q13936 9/20 0.43
ADRA1A P35348 4/20 0.43
ABCB11 O95342 4/20 0.43
TBXA2R P21731 3/20 0.43
SLC6A3 Q01959 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP3A4 P08684 3/20 0.43
ABCB1 P08183 3/20 0.43
ADORA3 P0DMS8 3/20 0.43
OPRM1 P35372 3/20 0.43
DRD3 P35462 3/20 0.43
KCNH2 Q12809 3/20 0.43
SCN5A Q14524 3/20 0.43
CYP1A2 P05177 3/20 0.43
NR1I2 O75469 3/20 0.43
LMNA P02545 3/20 0.43
HTR1A P08908 2/20 0.43
ADRA2A P08913 2/20 0.43
CHRM1 P11229 2/20 0.43
ADRB3 P13945 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9759993 0.92 CYP2C9 (0.52) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9761327 0.91 PYGL (0.41) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9761225 0.91 CACNA1C (0.46) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9760183 0.89 TBXA2R (0.42) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9761008 0.88 TBXA2R (0.39) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9760727 0.87 ADRA1A (0.47) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9760672 0.86 CYP2C9 (0.50) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9761425 0.86 TBXA2R (0.59) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL5459829 0.84 TBXA2R (0.60) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL9760769 0.81 TBXA2R (0.43) CACNA1CADRA1AABCB11TBXA2RSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026863-A Medicinal products in racemic or enantiomorph form; calcium channel blockers. hypotensive agents, cardiovascular disorders ADIR ET COMPAGNIE (FR) 1991-06-25 US disclosed
US-4983740-A Multistep; from 2- 2-/2-chloroethoxy/ethoxy!ethanol and potassium phthalimide ADIR ET COMPAGNIE (FR) 1991-01-08 US disclosed
US-4870091-A CALCIUM CHANNEL BLOCKERS ADIR ET CIE (FR) 1989-09-26 US disclosed